Etiology of neutropenia in HIV-infected patients

American Journal of Health-System Pharmacy

Volumn 56, Issue 24 SUPPL. 5, 1999, Pages

  Jaresko, George S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anti infective agents; Antiretroviral agents; Antivirals; Cidofovir; Foscarnet; Ganciclovir; HIV infections; Neutropenia; Sulfamethoxazole; Sulfonamides; Toxicity; Trimethoprim; Zi dovudine

Indexed keywords

ALPHA INTERFERON; CIDOFOVIR; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DAPSONE; DOXORUBICIN; FOSCARNET; GANCICLOVIR; HYDROXYUREA; PYRIMETHAMINE; RIBAVIRIN; STAVUDINE; SULFADIAZINE; ZIDOVUDINE;

BONE MARROW SUPPRESSION; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LEUKOCYTE COUNT; NEUTROPENIA; PRIORITY JOURNAL;

EID: 0033572633     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.suppl_5.s5     Document Type: Conference Paper

References (20)

1. Harbol AW, Liesveld JL, Simpson-Haidaris PJ et al. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev. 1994; 8:241-51.
2. Franklin LR, Dale DC. The role of colony stimulating factors in HIV disease. AIDS Reader. 1996; 6:185-93.
3. Pitrak DL, Bak PM, DeMarais P et al. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis. 1993; 167:1406-10.
4. Sullivan PS, Chu SY, Jones J et al. Epidemiology of hematologic manifestations of HIV infection. Blood. 1995; 86(10, suppl 1):559a.
5. Volberding PA, Lagakos SW, Koch MA et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in patients with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990; 322:941-9.
6. Fischl M, Parker C, Retinelli C et al. A randomized controlled trial of a reduced dose of zidovudine in patients with acquired immunodeficiency syndrome. N Engl J Med. 1990; 323:1009-14.
7. Abrams DI, Goldman AI, Launer C et al. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N Engl J Med. 1994; 330:657-62.
8. Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med. 1995; 333:1662-9.
9. Drew WL, Ives D, Lalezari JP et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 1995; 333:615-20.
10. Spector SA, Wecingeist T, Pollard RB et al. A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis. 1993; 168:557-63.
11. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991; 324:1332-8.
12. Keiser P, Rademacher S. G-CSF use is associated with prolonged survival in HIV infected patients with Mycobacterium avium complex. Paper presented at 3rd Conference on Retroviruses and Opportunistic Infections. 1996. Abstract 192.
13. Warren E, George S, You J et al. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia. Pharmacotherapy. 1997; 17:900-16.
14. Smith C, Lilly S, Mann KP et al. AIDS-related malignancies. Ann Med. 1998; 30:323-44.
15. Bodey GP, Buckley M, Sathe YS et al. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64:328-40.
16. Tumbarello M, Tacconelli E, Caponera S et al. The impact of bacteremia on HIV infection: nine years experience in a large Italian university hospital. J Infect. 1995; 31:123-31.
17. Jacobson MA, Cohen PT, Liu RC et al. Risk of hospitalization for serious bacterial infection (SBI) associated with neutropenia severity in patients with HIV disease. Paper presented at 11th International Conference on AIDS. Vancouver, BC; 1996.
18. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med. 1995; 155:1965-70.
19. Rancourt J, Ross JW. Documented cost savings with low dose filgrastim for HIV inpatients. Int Conf AIDS, 1998; 12:549. Abstract 32147.
20. Engles-Horton LL, Skowronski C, Mostashari F et al. Clinical guidelines and pharmacist intervention program for HIV-infected patients requiring granulocyte colony-stimulating factor therapy. Pharmacothrapy. 1999; 19:356-62.